Artivion, Inc. (AORT) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
AORT Revenue Growth
Revenue Breakdown (FY 2025)
AORT's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
AORT Revenue Analysis (2014–2025)
As of May 8, 2026, Artivion, Inc. (AORT) generated trailing twelve-month (TTM) revenue of $458.7 million, reflecting strong growth of +17.5% year-over-year. The most recent quarter (Q1 2026) recorded $116.3 million in revenue, up 0.3% sequentially.
Looking at the longer-term picture, AORT's 5-year compound annual growth rate (CAGR) stands at +11.8%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $441.3 million in 2025, representing a new all-time high.
Revenue diversification analysis shows AORT's business is primarily driven by Aortic Stent Grafts (36%), On X (23%), and Preservation Services (22%).
When compared to Healthcare sector peers including NVCR (+8.5% YoY), ATRC (+15.0% YoY), and NNOX (+15.2% YoY), AORT has underperformed the peer group in terms of revenue growth. Compare AORT vs NVCR →
AORT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AORTCurrent | $459M | +17.5% | +11.8% | 6.1% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ATRC | $535M | +15.0% | +20.9% | -0.6% | |
 NNOX | $11M | +15.2% | - | -502.9% | |
 TMDX | $605M | +30.2% | +88.2% | 17.9% | |
 MASI | $1.5B | -14.4% | +5.9% | 20.5% |
AORT Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $441.3M | +13.6% | $270.5M | 61.3% | $26.7M | 6.1% |
| 2024 | $388.5M | +9.8% | $248.8M | 64.0% | $38.9M | 10.0% |
| 2023 | $354.0M | +12.8% | $229.2M | 64.7% | $5.7M | 1.6% |
| 2022 | $313.8M | +5.0% | $202.5M | 64.5% | $6.2M | 2.0% |
| 2021 | $298.8M | +18.0% | $197.5M | 66.1% | $8.1M | 2.7% |
| 2020 | $253.2M | -8.3% | $167.8M | 66.3% | $2.4M | 1.0% |
| 2019 | $276.2M | +5.1% | $183.0M | 66.3% | $17.0M | 6.2% |
| 2018 | $262.8M | +38.6% | $173.0M | 65.8% | $9.3M | 3.5% |
| 2017 | $189.7M | +5.2% | $128.6M | 67.8% | $8.0M | 4.2% |
| 2016 | $180.4M | +23.6% | $118.9M | 65.9% | $21.8M | 12.1% |
See AORT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AORT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AORT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAORT — Frequently Asked Questions
Quick answers to the most common questions about buying AORT stock.
Is AORT's revenue growth accelerating or slowing?
AORT revenue is accelerating at +17.5% year-over-year, exceeding the 5-year CAGR of +11.8%. TTM revenue reached $459M. Growth momentum has increased versus prior periods.
What is AORT's long-term revenue growth rate?
Artivion, Inc.'s 5-year revenue CAGR of +11.8% reflects the sustained expansion pattern. Current YoY growth of +17.5% is above this long-term average.
How is AORT's revenue distributed by segment?
AORT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.